Prebiotics and lipid metabolism: Review of experimental and human data

Handbook of Prebiotics

Volumn , Issue , 2008, Pages 209-218

  Delzenne, Nathalie M ^a   Neyrinck, Audrey M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956062004     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (100)

1. Ley, R.E., et al. Microbial ecology: Human gut microbes associated with obesity, Nature, 444,1022,2006.
2. Ley, R.E., et al. Obesity alters gut microbial ecology, Proc. Natl. Acad. Sci. USA, 102, 11070, 2005.
3. Turnbaugh, P.J., et al. An obesity-associated gut microbiome with increased capacity for energy harvest, Nature, 444,1027, 2006.
4. Backhed, F., et al. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice, Proc. Natl. Acad. Sci. USA, 104, 979, 2007.
5. Rawls, J.F., et al. Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection, Cell, 127, 423,2006.
6. Backhed, F., et al. The gut microbiota as an environmental factor that regulates fat storage, Proc. Natl. Acad. Sci. USA, 101, 15718, 2004.
7. Roberfroid, M.B. and Delzenne, N.M. Dietary fructans, Annu. Rev. Nutr., 18, 117, 1998.
8. Scheppach, W., Luehrs, H. and Menzel, T. Beneficial health effects of, Br J Nutr, 85, S22, 2001.
9. Delzenne, N.M. and Williams, C. (1999): Actions of non-digestible carbohydrates on blood lipids in humans and animals. In: Colonic Microbiota, Nutrition and Health, edited by G. Gibson, et al., pp. 213-232. Kluwer Academic Publisher, The Netherlands.
10. Daubioul, C.A., et al. Dietary oligofructose lessens hepatic steatosis, but does not prevent hypertriglyceridemia in obese zucker rats, J. Nutr., 130, 1314,2000.
11. Delzenne, N.M. and Kok, N. Effects of fructans-type prebiotics on lipid metabolism, Am. J. Clin. Nutr., 73, 456S, 2001.
12. Cheng, H.H. and Lai, M.H. Fermentation of resistant rice starch produces propionate reducing serum and hepatic cholesterol in rats, J. Nutr., 130, 1991, 2000.
13. Lopez, H.W., et al. Class 2 resistant starches lower plasma and liver lipids and improve mineral retention in rats, J. Nutr., 131, 1283, 2001.
14. Diez, M., et al. Influence of a blend of fructo-oligosaccharides and sugar beet fiber on nutrient digestibility and plasma metabolite concentrations in healthy beagles, Am. J. Vet. Res., 58, 1238,1997.
15. Hokfelt, T., et al. Galanin and NPY, two peptides with multiple putative roles in the nervous system, Horm. Metab. Res., 31, 330, 1999.
16. Tokunaga, T., Oku, T. and Hosoya, N. Influence of chronic intake of new sweetener fructooligosaccharide (Neosugar) on growth and gastrointestinal function of the rat, J. Nutr. Sci. Vitaminol. (Tokyo), 32, 111, 1986.
17. Rault-Nania, M.H., et al. Inulin attenuates atherosclerosis in apolipoprotein E-deficient mice, Br. J. Nutr., 96, 840, 2006.
18. Busserolles, J., et al. Oligofructose protects against the hypertriglyceridemic and pro-oxidative effects of a high fructose diet in rats, J. Nutr., 133,1903,2003.
19. Kok, N., Roberfroid, M. and Delzenne, N. Dietary oligofructose modifies the impact of fructose on hepatic triacylglycerol metabolism, Metabolism, 45, 1547, 1996.
20. Daubioul, C., et al. Dietary fructans, but not cellulose, decrease triglyceride accumulation in the liver of obese Zucker fa/fa rats, J. Nutr., 132, 967,2002.
21. Sugatani, J., et al. Dietary inulin alleviates hepatic steatosis and xenobiotics-induced liver injury in rats fed a high-fat and high-sucrose diet: Association with the suppression of hepatic cytochrome P450 and hepatocyte nuclear factor 4alpha expression, Drug Metab. Dispos., 34, 1677,2006.
22. Fiordaliso, M., et al. Dietary oligofructose lowers triglycerides, phospholipids and cholesterol in serum and very low density lipoproteins of rats, Lipids, 30, 163,1995.
23. Trautwein, E.A., Rieckhoff, D. and Erbersdobler, H.F. Dietary inulin lowers plasma cholesterol and triacylglycerol and alters biliary bile acid profile in hamsters, J. Nutr., 128, 1937,1998.
24. Delzenne, N.M. and Kok, N. Effects of fructans-type prebiotics on lipid metabolism, Am. J. Clin. Nutr., 73, 456S, 2001.
25. Takase, S., Goda, T. and Watanabe, M. Monostearoylglycerol-starch complex: Its digestibility and effects on glycemic and lipogenic responses, J. Nutr. Sci. Vitaminol., 40,23,1994.
26. Higgins, J.A., Brown, M.A. and Storlien, L.H. Consumption of resistant starch decreases postprandial lipogenesis in white adipose tissue of the rat, Nutr. J., 5, 25, 2006.
27. Delzenne, N.M. and Williams, C.M. Prebiotics and lipid metabolism, Curr. Opin. Linidol, 13, 61, 2002
28. Ferre, P. and Foufelle, F. SREBP-1c transcription factor and lipid homeostasis: clinical perspective, Horm. Res., 68, 72,2007.
29. Kang, S.A., et al. Altered mRNA expression of hepatic lipogenic enzyme and PPARalpha in rats fed dietary levan from Zymomonas mobilis, J. Nutr. Biochem., 17,419,2006.
30. Lopez, H.W., et al. Effects of soluble corn bran arabinoxylans on cecal digestion, lipid metabolism, and mineral balance (Ca, Mg) in rats, J. Nutr. Biochem., 10,500, 1999.
31. Fukushima, M., et al. Low density lipoprotein receptor mRNA in rat liver is affected by resistant starch of beans, Lipids, 36, 129,2001.
32. Delzenne, N.M., et al. Inulin and oligofructose modulate lipid metabolism in animals: Review of biochemical events and future prospects, Br. J. Nutr., 87, S255, 2002.
33. Fava, F., et al. The gut microbiota and lipid metabolism: Implications for human health and coronary heart disease, Curr. Med. Chem., 13, 3005, 2006.
34. Levrat, M.A., Remesy, C. and Demigne, C. High propionic acid fermentations and mineral accumulation in the cecum of rats adapted to different levels of inulin, J. Nutr., 121,1730, 1991.
35. Mortensen, A., Poulsen, M. and Frandsen, H. Effect of a long-chained fructan Raftiline HP on blood lipids and spontaneous atherosclerosis in low density receptor knockout mice, Nutr. Res., 22,473, 2002.
36. Adam, A., et al. Whole wheat and triticale flours with differing viscosities stimulate cecal fermentations and lower plasma and hepatic lipids in rats, J. Nutr., 131, 1770,2001.
37. Trautwein, E.A., et al. Impact of beta-cyclodextrin and resistant starch on bile acid metabolism and fecal steroid excretion in regard to their hypolipidemic action in hamsters, BBA Mol. Cell Biol. L., 1437, 1,1999.
38. Wouters, K., et al. Understanding hyperlipidemia and atherosclerosis: Lessons from genetically modified apoe and ldlr mice, Clin. Chem. Lab. Med., 43, 470, 2005.
39. Ranganna, K., et al. Butyrate inhibits proliferation-induced proliferating cell nuclear antigen expression (PCNA) in rat vascular smooth muscle cells, Mol. Cell Biochem, 205, 149,2000.
40. Harris, H.W., Gosnell, J.E. and Kumwenda, Z.L. The lipemia of sepsis: Triglyceride-rich lipoproteins as agents of innate immunity, J. Endotoxin. Res., 6, 421, 2000.
41. Berbee, J.F., Havekes, L.M. and Rensen, P.C. Apolipoproteins modulate the inflammatory response to lipopolysaccharide, J. Endotoxin. Res., 11, 97, 2005.
42. Aspichueta, P., et al. Impaired response of VLDL lipid and apoB secretion to endotoxin in the fasted rat liver, J. Endotoxin. Res., 12,181, 2006.
43. Buddington, R.K., et al. Non-digestible oligosaccharides and defense functions: Lessons learned from animal models, Br. J. Nutr., 87, S231, 2002.
44. Schley, P.D. and Field, C.J. The immune-enhancing effects of dietary fibres and prebiotics, Br. J. Nutr., 87, S221, 2002.
45. Buddington, K.K., Donahoo, J.B. and Buddington, R.K. Dietary oligofructose and inulin protect mice from enteric and systemic pathogens and tumor inducers, J. Nutr., 132, 472, 2002.
46. Neyrinck, A.M., Alexiou, H. and Delzenne, N.M. Kupffer cell activity is involved in the hepatoprotective effect of dietary oligofructose in rats with endothermic shock, J Nutr, 134, 1124, 2004.
47. Koutelidakis, I., et al. Systemic endotoxaemia following obstructive jaundice: The role of lactulose, J. Surg. Res., 113,243, 2003.
48. Lerer-Metzger, M., et al. Effects of long-term low-glycaemic index starchy food on plasma glucose and lipid concentrations and adipose tissue cellularity in normal and diabetic rats, Br. J. Nutr., 75, 723, 1996.
49. Cani, P.D., Dewever, C. and Delzenne, N.M. Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagon-like peptide-1 and ghrelin) in rats, Br. J. Nutr., 92, 521,2004.
50. Cani, P.D., et al. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor, Diabetes, 55, 1484, 2006.
51. Delmee, E., et al. Relation between colonic proglucagon expression and metabolic response to oligofructose in high fat diet-fed mice, Life Sci., 79, 1007, 2006.
52. Cani, P.D., et al. Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats, Br. J. Nutr., 1,2007.
53. Xiong, Y., et al. Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41, Proc. Natl. Acad. Sci. USA, 101, 1045, 2004.
54. Andersson, H., et al. Health effects of probiotics and prebiotics. A literature review on human studies, Scand. J. Nutr., 45,48,2001.
55. Taylor, G.R.J. and Williams, C.M. Effects of probiotics and prebiotics on blood lipids, Br. J. Nutr., 80, S225,1998.
56. Whelan, K., et al. The role of probiotics and prebiotics in the management of diarrhoea associated with enteral tube feeding, J. Hum. Nutr. Diet, 14,423,2001.
57. McNaught, C.E. and MacFie, J. Probiotics in clinical practice: A critical review of the evidence, Nurs. Res., 21, 343, 2001.
58. St Onge, M.P., Farnworth, E.R. and Jones, P.J. Consumption of fermented and nonfermented dairy products: Effects on cholesterol concentrations and metabolism, Am. J. Clin. Nutr., 71, 674,2000.
59. Fabian, E. and Elmadfa, I. Influence of daily consumption of probiotic and conventional yoghurt on the plasma lipid profile in young healthy women, Ann. Nutr. Metab., 50, 387,2006.
60. Yamamoto, Y., et al. In vitro digestibility and fermentability of levan and its hypocholesterolemic effects in rats, J. Nutr. Biochem., 10, 13, 1999.
61. Usman and Hosono, A. Effect of administration of Lactobacillus gasseri on serum lipids and fecal steroids in hypercholesterolemic rats, J. Dairy Sci., 83,1705,2000.
62. Schaafsma, G., et al. Effects of a milk product, fermented by Lactobacillus acidophilus and with fructo-oligosaccharides added, on blood lipids in male volunteers, Eur. J. Clin. Nutr., 52, 436, 1998.
63. Jenkins, D.J., et al. Colonic bacterial activity and serum lipid risk factors for cardiovascular disease, Metabolism, 48, 264,1999.
64. Demigne, C., Remesy, C. and Morand, C. (1999): Short chain fatty acids. In: Colonic microbiota, nutrition and health, edited by G. Gibson, et al., pp. 55-63. Kluwer Academic Publisher, The Netherlands.
65. Delzenne, N.M. and Kok, N. Effects of fructans-type prebiotics on lipid metabolism, Am. J. Clin. Nutr., 73, 456S, 2001.
66. Demigne, C., et al. Effect of propionate on fatty acid and cholesterol synthesis and on acetate metabolism in isolated rat hepatocytes, Br. J. Nutr., 74, 209, 1995.
67. Jenkins, D.J., et al. Physiological effects of resistant starches on fecal bulk, short chain fatty acids, blood lipids and glycemic index, J. Am. Coll. Nutr., 17, 609, 1998.
68. Sakakibara, S., et al. Acetic acid activates hepatic AMPK and reduces hyperglycemia in diabetic KK-A(y) mice, Biochem. Biophys. Res. Commun., 344, 597, 2006.
69. Williams, C.M. and Jackson, K.G. Inulin and oligofructose: Effects on lipid metabolism from human studies, Br. J. Nutr., 87, S261, 2002.
70. Beylot, M., Effects of inulin-type fructans on lipid metabolism in man and in animal models, Br. J. Nutr., 93, S163, 2005.
71. Daubioul, C.A., et al. Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: Results of a pilot study, Eur. J. Clin. Nutr., 59, 723, 2005.
72. Gallaher, D.D., et al. A glucomannan and chitosan fiber supplement decreases plasma cholesterol and increases cholesterol excretion in overweight normocho-lesterolemic humans, J. Am. Coll. Nutr., 21, 428, 2002.
73. Yamashita, K., Itakura, M. and Kawai, K. Effects of fructo-oligosaccharides on blood glucose and serum lipids in diabetics subjects, Nutr. Res., 4, 961, 1984.
74. Walsh, D.E., Yaghoubian, V. and Behforooz, A. Effect of glucomannan on obese patients: A clinical study, Int. J. Obes., 8,289,1984.
75. Hidaka, H., Tashiro, Y. and Eida, T. Proliferation of bifidobacteria by oligosaccharides and their useful effect on human health. Bifidobacteria Microflora 10, 65, 1991.
76. Vido, L., et al. Childhood obesity treatment: Double blinded trial on dietary fibres (glucomannan) versus placebo, Padiatr. Padol., 28,133, 1993.
77. Arvill, A. and Bodin, L. Effect of short-term ingestion of konjac glucomannan on serum cholesterol in healthy men, Am. J. Clin. Nutr., 61, 585, 1995.
78. Luo, J., et al. Chronic consumption of short-chain fructooligosaccharides by healthy subjects decreased basal hepatic glucose production but had no effect on insulin-stimulated glucose metabolism, Am. J. Clin. Nutr., 63, 939, 1996.
79. Pedersen, A., Sandstrom, B. and VanAmelsvoort, J.M.M. The effect of ingestion of inulin on blood lipids and gastrointestinal symptoms in healthy females, Br. J. Nutr., 78,215, 1997.
80. Davidson, M.H., et al. Effects of dietary inulin on serum lipids in men and women with hypercholesterolemia, Nutr. Res., 18, 503,1998.
81. Jackson, K.G., et al. The effect of the daily intake of inulin on fasting lipid, insulin and glucose concentrations in middle-aged men and women, Br. J. Nutr., 82,23, 1999.
82. Brighenti, F., et al. Effect of consumption of a ready-to-eat breakfast cereal containing inulin on the intestinal milieu and blood lipids in healthy male volunteers, Eur. J. Clin. Nutr., 53, 726,1999.
83. Alles, M.S., et al. Consumption of fructooligosaccharides does not favorably affect blood glucose and serum lipid concentrations in patients with type 2 diabetes, Am. J. Clin. Nutr., 69, 64, 1999.
84. Havenaar, R., et al. Inulin: Fermentation and microbial ecology in the intestinal tract, Food Rev. Int, 15, 109,1999.
85. Luo, J., et al. Chronic consumption of short-chain fructooligosaccharides does not affect basal hepatic glucose production or insulin resistance in type 2 diabetics, L Nutr, 130, 1572, 2000.
86. Causey, J.L., et al. Effects of dietary inulin on serum lipids, blood glucose and the gastrointestinal, environment in hypercholesterolemic men, Nutr. Res., 20, 191.2000.
87. Vuksan, V., et al. Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: Results of a controlled metabolic trial, Diab. Care, 23, 9, 2000.
88. Balcazar-Munoz, B.R., Martinez-Abundis, E. and Gonzalez-Ortiz, M. Effect of oral inulin administration on lipid profile and insulin sensitivity in dyslipidemic obese subjects, Revista Medica de Chile, 131, 597,2003.
89. Letexier, D., Diraison, F. and Beylot, M. Addition of inulin to a moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans, Am. J. Clin. Nutr., 77, 559,2003.
90. Chen, H.L., et al. Konjac supplement alleviated hypercholesterolemia and hyperglycemia in type 2 diabetic subjects—A randomized double-blind trial, J. Am. Coll. Nutr., 22, 36,2003.
91. Giacco, R., et al. Effects of short-chain fructo-oligosaccharides on glucose and lipid metabolism in mild hypercholesterolaemic individuals, Clin. Nutr., 23,331, 2004.
92. Martino, F., et al. Effect of dietary supplementation with glucomannan on plasma total cholesterol and low density lipoprotein cholesterol in hypercho-lesterolemic children, Nutr. Metab. Cardiovasc. Dis., 15, 174,2005.
93. Yoshida, M., et al. Effect of plant sterols and glucomannan on lipids in individuals with and without type II diabetes, Eur. J. Clin. Nutr., 60, 529, 2006.
94. Vogt, J.A., et al. L-rhamnose and lactulose decrease serum triacylglycerols and their rates of synthesis, but do not affect serum cholesterol concentrations in men, J. Nutr., 136, 2160, 2006.
95. Wood, R.J., et al. Effects of a carbohydrate-restricted diet with and without supplemental soluble fiber on plasma low-density lipoprotein cholesterol and other clinical markers of cardiovascular risk, Metabolism, 56, 58, 2007.
96. Jenkins, D.J. and Kendall, C.W. Resistant starches, Curr. Opin. Gastroenterol., 16, 178.2000.
97. Lovegrove, J.A., et al. Modest doses of beta-glucan do not reduce concentrations of potentially atherogenic lipoproteins, Am. J. Clin. Nutr., 72, 49, 2000.
98. Pomeroy, S., et al. Oat beta-glucan lowers total and LDL-cholesterol, Aust. J. Nutr. Diet, 58, 51,2001.
99. Battilana, P., et al. Mechanisms of action of beta-glucan in postprandial glucose metabolism in healthy men, Eur. J. Clin. Nutr., 55, 327, 2001.
100. Ferchaud-Roucher, V., et al. Colonic fermentation from lactulose inhibits lipoly-sis in overweight subjects, Am. J. Physiol. Endocrinol. Metab, 289, E716-E720, 2005.